Merck KGaA 13D and 13G filings for F-star Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-08 5:00 pm Sale |
2021-12-31 | 13G | F-star Therapeutics, Inc. FSTX |
Merck KGaA | 75,140 0.100% |
-418,570 (-84.78%) |
Filing |
| 2021-02-01 4:32 pm Purchase |
2020-12-31 | 13G | F-star Therapeutics, Inc. FSTX |
Merck KGaA | 493,710 5.400% |
493,710 (New Position) |
Filing |